Plant Systems as Platforms for the Production of Interferon Alpha and its Application - Cytology and Genetics
Abstract Interferon alpha (IFN) is a small glycosylated polypeptide used in the treatment of cancer, immune disorders, and various other related diseases. Demands for human and veterinary medicine in safe sources of this remedy motivate investigations for new interferon production systems. Plants expressing IFN can become an excellent substitution for traditional bacterial systems. Among the advantages of plant-based human IFN are correct glycosylation, lack of toxins and pathogens, and unexpansive production costs. The effectiveness of different plant-based systems for IFN production is compared. Oral administration of IFN produced in edible plants is a promising direction for the lack of demand for purification of the protein, its effective storage, and safe mode of the protein delivery to the competent tissues of a treated organism. The advantages of edible plants as fortified vectors for interferon delivery are discussed. Examples of oral administration of IFN from different production systems are compared. Oral usage of human IFN from various production systems in veterinary is viewed.
#Newswire: ORF Genetics has successfully secured €5 million in a new financing round, with participation from both existing and new shareholders. The capital will enable the company to significantly scale up production capacity of its specialized proteins, which are key components in cultivated meat production. Arctica Finance served as financial advisor for the capital raise.
#cellculture #meat #ingredients #protein #molecularfarming #growthfactors #biotech
https://www.proteinreport.org/newswire/orf-genetics-secures-euro5-million-accelerate-cultivated-meat-production/
ORF Genetics Secures €5 Million to Accelerate Cultivated Meat Production
ORF Genetics has successfully secured €5 million in a new financing round, with participation from both existing and new shareholders. The capital will enable the company to significantly scale up production capacity of its specialized proteins, which are key components in cultivated meat production. Arctica Finance served as financial advisor for the capital raise.
#Newswire: PoLoPo, the B2B deeptech company developing high-protein potato varieties, today announced a strategic shift to focus on the snack industry. The company’s patented potato variety delivers up to three times the protein of conventional tubers, offering brands and food manufacturers improved varieties for making high-protein chips.
#plantprotein #ingredients #potatoes #molecularfarming #protein #agtech #biotech #foodtech #israel #snackfoods #cpg #pressrelease
https://www.proteinreport.org/newswire/polopo-shifts-focus-high-protein-potatoes-chips-industry/
PoLoPo Shifts Focus to High-Protein Potatoes for the Chips Industry
PoLoPo, a B2B deeptech company developing high-protein potato varieties, today announced a strategic shift to focus on the snack industry.
Modern Agriculture Foundation Launches Global Call for Nominations: Leading Women in Foodtech 2025
The Modern Agriculture Foundation (MAF) proudly launches the third annual "Leading Women in Foodtech 2025" recognition program – an esteemed international honor awarded to inspiring women making a tangible impact on the future of the global food industry.
#Newswire: Molecular farming company PoLoPo today announced it will begin supplying patatin, the native protein in potatoes, to commercial clients following regulatory approval.
#molecularfarming #eggs #ingredients #biotech #foodtech #pressrelease
https://www.proteinreport.org/newswire/polopo-adds-potato-protein-patatin-product-lineup/
PoLoPo Adds Potato Protein (Patatin) to Product Lineup
PoLoPo, a molecular farming pioneer, today announced it will begin supplying patatin, the native protein in potatoes, to commercial clients following regulatory approval.
#Newswire: Israel molecular farming pioneer PoLoPo today announced its SuperAA platform, which turns the potato plant into a micro-biofactory that manufactures egg protein (ovalbumin) through proprietary metabolic engineering techniques.
#molecularfarming #eggs #protein #biotech #foodtech #innovation #sustainability #israel #pressrelease
https://www.proteinreport.org/newswire/polopo-unveils-superaa-platform-protein-biofactory-in-potato/
PoLoPo Unveils SuperAA Platform: Protein Biofactory in Potato
PoLoPo, a molecular farming pioneer, today announced its SuperAA platform, the first step to producing proteins in common plant crops. The platform is currently deployed in potatoes at greenhouse scale to generate both a native protein (patatin) as well as egg protein (ovalbumin) through proprietary metabolic engineering techniques.
ORF Genetics and Seawith Enter into Partnership for Growth Factors and Cultivated Meat Production
The Icelandic ORF Genetics and the South Korean company SeaWith have announced a pioneering partnership to boost the production of cultivated meat using ORF’s MESOkine animal-free growth factors made from barley.
#Newswire: The biotechnology startup providing animal-free recombinant growth factors at a fraction of their current cost and with a reduced carbon footprint, Tiamat Sciences Corp., today announced its $2 million seed-extension financing round led by 8090 Industries.
#molecularfarming #biotech #cellag #meat #ingredients #protein #startups #innovation #sustainability #investing #pressrelease
https://www.proteinreport.org/newswire/female-owned-biotech-startup-tiamat-sciences-raise-extension-2m-accelerate-product
Female-owned biotech startup Tiamat Sciences raise an extension of $2M to accelerate product validation and strategic partnerships
Biotechnology startup Tiamat Sciences today announced its $2 million seed-extension financing round led by 8090 Industries with participation from new and existing investors.
Cytology and Genetics
Protein Report